By activating ALX/FPR2 and ChemR23 receptors, resolvins modulate glia–neuron crosstalk and reduce neuronal hyperexcitability, providing neuroprotective effects in post-viral neuropathy and COVID-19–associated neuroinflammation [4,85]. This evidence concerns the gene FPR2 and COVID-19.